Logo image of MIST

MILESTONE PHARMACEUTICALS IN (MIST) Stock Overview

NASDAQ:MIST - CA59935V1076 - Common Stock

1.84 USD
+0.03 (+1.66%)
Last: 8/29/2025, 8:00:01 PM
1.8399 USD
0 (-0.01%)
After Hours: 8/29/2025, 8:00:01 PM

MIST Key Statistics, Chart & Performance

Key Statistics
52 Week High2.75
52 Week Low0.63
Market Cap156.38M
Shares84.99M
Float81.93M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.85
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10/bmo
IPO05-09 2019-05-09
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


MIST short term performance overview.The bars show the price performance of MIST in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15 20 25

MIST long term performance overview.The bars show the price performance of MIST in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40 -60

The current stock price of MIST is 1.84 USD. In the past month the price increased by 28.67%. In the past year, price increased by 29.58%.

MILESTONE PHARMACEUTICALS IN / MIST Daily stock chart

MIST Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 45.36 693.36B
JNJ JOHNSON & JOHNSON 17.72 426.69B
NVO NOVO-NORDISK A/S-SPONS ADR 14.44 250.88B
AZN ASTRAZENECA PLC-SPONS ADR 18 247.73B
NVS NOVARTIS AG-SPONSORED ADR 14.3 244.98B
MRK MERCK & CO. INC. 10.92 210.11B
PFE PFIZER INC 7.3 140.77B
SNY SANOFI-ADR 11.17 120.68B
BMY BRISTOL-MYERS SQUIBB CO 7.01 96.03B
GSK GSK PLC-SPON ADR 8.76 79.97B
ZTS ZOETIS INC 25.14 69.31B
TAK TAKEDA PHARMACEUTIC-SP ADR 49.97 47.34B

About MIST

Company Profile

MIST logo image Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. The company is headquartered in Montreal, Quebec and currently employs 33 full-time employees. The company went IPO on 2019-05-09. The firm is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The firm is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.

Company Info

MILESTONE PHARMACEUTICALS IN

420-1111 boul. Dr.-Frederik-Philips

MONTREAL QUEBEC H4M 2X6 CA

CEO: Joseph Oliveto

Employees: 33

MIST Company Website

MIST Investor Relations

Phone: 15143360444

MILESTONE PHARMACEUTICALS IN / MIST FAQ

What is the stock price of MILESTONE PHARMACEUTICALS IN today?

The current stock price of MIST is 1.84 USD. The price increased by 1.66% in the last trading session.


What is the ticker symbol for MILESTONE PHARMACEUTICALS IN stock?

The exchange symbol of MILESTONE PHARMACEUTICALS IN is MIST and it is listed on the Nasdaq exchange.


On which exchange is MIST stock listed?

MIST stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for MILESTONE PHARMACEUTICALS IN stock?

10 analysts have analysed MIST and the average price target is 3.4 USD. This implies a price increase of 84.78% is expected in the next year compared to the current price of 1.84. Check the MILESTONE PHARMACEUTICALS IN stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MILESTONE PHARMACEUTICALS IN worth?

MILESTONE PHARMACEUTICALS IN (MIST) has a market capitalization of 156.38M USD. This makes MIST a Micro Cap stock.


How many employees does MILESTONE PHARMACEUTICALS IN have?

MILESTONE PHARMACEUTICALS IN (MIST) currently has 33 employees.


What are the support and resistance levels for MILESTONE PHARMACEUTICALS IN (MIST) stock?

MILESTONE PHARMACEUTICALS IN (MIST) has a support level at 1.75 and a resistance level at 1.85. Check the full technical report for a detailed analysis of MIST support and resistance levels.


Should I buy MILESTONE PHARMACEUTICALS IN (MIST) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MILESTONE PHARMACEUTICALS IN (MIST) stock pay dividends?

MIST does not pay a dividend.


When does MILESTONE PHARMACEUTICALS IN (MIST) report earnings?

MILESTONE PHARMACEUTICALS IN (MIST) will report earnings on 2025-11-10, before the market open.


What is the Price/Earnings (PE) ratio of MILESTONE PHARMACEUTICALS IN (MIST)?

MILESTONE PHARMACEUTICALS IN (MIST) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.85).


What is the Short Interest ratio of MILESTONE PHARMACEUTICALS IN (MIST) stock?

The outstanding short interest for MILESTONE PHARMACEUTICALS IN (MIST) is 6.9% of its float. Check the ownership tab for more information on the MIST short interest.


MIST Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to MIST. When comparing the yearly performance of all stocks, MIST is one of the better performing stocks in the market, outperforming 81.52% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MIST Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to MIST. MIST has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MIST Financial Highlights

Over the last trailing twelve months MIST reported a non-GAAP Earnings per Share(EPS) of -0.85. The EPS increased by 16.76% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -117.11%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-42.86%
Sales Q2Q%N/A
EPS 1Y (TTM)16.76%
Revenue 1Y (TTM)-100%

MIST Forecast & Estimates

10 analysts have analysed MIST and the average price target is 3.4 USD. This implies a price increase of 84.78% is expected in the next year compared to the current price of 1.84.


Analysts
Analysts78
Price Target3.4 (84.78%)
EPS Next Y-25.83%
Revenue Next YearN/A

MIST Ownership

Ownership
Inst Owners20.29%
Ins Owners3.61%
Short Float %6.9%
Short Ratio3.67